The combined trial at Eastchester currently has two patients with a few more people joining soon, while the CP-613 solo trial has one patient and two more to come shortly, according to Avi Kamelhar, the executive director at the Center.
Other local trial facilities are spread throughout the country, he
"These patients don't have any other hope and this is giving them something," Kamelhar
and the rest of the Eastchester Center
staff express great faith in Shorr's project and hope to see continued positive results.